Explore comprehensive CDMO services offered by OmniBio, supporting end-to-end Anlaytical Testing, Artificial Intelligence (AI), Drug Development and Manufacturing. OmniBio enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Canada
Description: OmniaBio Inc. is a Canadian cell and gene therapy CDMO (Contract Development and Manufacturing Organization) headquartered in Hamilton, Ontario. It operates as a subsidiary of the Centre for Commercialization of Regenerative Medicine (CCRM) and was founded in 2022 to accelerate the industrialization of advanced therapies (ATMPs), including CAR-T, iPSC-derived therapies, and viral vectors.
